Clinical Trials on Primary Hyperlipidemia or Mixed Dyslipidemia in Australia
Total 339 results
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaSwitzerland, Saudi Arabia, United Arab Emirates, United Kingdom, Austria, Israel, China, Malaysia
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
University of South AustraliaAmerican Egg BoardCompletedHypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical InactivityAustralia
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaGreece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Spain, Finland, Sweden, Canada
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Belgium, Germany, Hong Kong, Netherlands, France, Australia, Canada, South Africa, United Kingdom, Spain, Poland, Switzerland
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, United States, Australia
-
AmgenCompletedHyperlipidemiaCanada, Denmark, France, United States, Czechia, New Zealand, Australia, South Africa, Italy, United Kingdom, Netherlands, Germany, Norway
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Canada
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, France, Italy, Czechia, Taiwan, Switzerland, Korea, Republic of, Germany, Hong Kong, Netherlands, Australia, Belgium, Canada, Hungary, South Africa, Russian Federation, Spain, United Kingdom, Sweden, Mexico
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Taiwan, Korea, Republic of, Australia, Belgium, Canada, South Africa, France, Turkey
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
AmgenCompletedSubjects With Hyperlipidemia, Dyslipidemia and HIV InfectionCanada, France, United States, Belgium, Italy, Spain, Switzerland, United Kingdom, South Africa, Portugal, Australia, Greece, Brazil, Romania, Poland
-
AmgenCompletedHypercholesterolaemiaAustria, Italy, Belgium, Czechia, Switzerland, Spain, Slovakia, Germany, Portugal, Greece, Bulgaria, Sweden
-
HighTide Biopharma Pty LtdCompletedHypercholesterolemiaAustralia
-
PfizerCompletedHyperlipidemia | Hypercholesterolemia, FamilialAustralia, Canada, United States, France, South Africa, Sweden, Norway, Denmark, Iceland
-
Swisse Wellness Pty LtdCommonwealth Scientific & Industrial Research Organisation; BIONAP SRLCompletedInvestigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (CLoNE)HypercholesterolemiaAustralia
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); The University of New South... and other collaboratorsCompletedHIV Infections | Cardiovascular Disease | Lipodystrophy | Glucose Metabolism | Lipid Metabolism | Metabolic AbnormalityAustralia
-
AmgenCompletedHyperlipidemiaCanada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
-
Marea TherapeuticsRecruiting
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaBrazil, Turkey, Taiwan, Argentina, India, Philippines, Singapore, Thailand, Australia, Chile, South Africa, Jordan, Korea, Republic of, Lebanon, United Arab Emirates, Malaysia, Peru, Israel, Indonesia, Guatemala, Hong Kong, Kuwait, ... and more
-
AstraZenecaCompleted
-
The George InstitutePfizer; Royal Prince Alfred Hospital, Sydney, Australia; Lipid and Cardiovascular... and other collaboratorsCompletedHypercholesterolemiaAustralia
-
The University of Western AustraliaNational Health and Medical Research Council, AustraliaUnknownFamilial Hypercholesterolaemia | HypertriglyceridaemiaAustralia
-
Affiris AGMedical University of ViennaCompleted
-
Medical University of GrazCompletedFluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular RiskHypercholesterolemiaAustria
-
Vaxxinity, Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
Mylan Inc.Mylan Österreich GmbH; Mylan Germany GmbH; Mylan Healthcare Sp. z o.o.CompletedHypercholesterolemiaGermany, Austria
-
Medical University of ViennaUnknown
-
Medical University of ViennaUnknown
-
Daiichi Sankyo, Inc.CompletedHypercholesterolemiaUnited States, South Africa, Israel, Netherlands, Canada, Norway, Austria, Australia
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Arrowhead PharmaceuticalsActive, not recruitingHomozygous Familial HypercholesterolemiaAustralia, Canada, United States, South Africa
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Australia, Austria, Netherlands, Taiwan, Ukraine
-
Austrian Academic Institute for Clinical NutritionMedical University of ViennaCompletedHeterozygous Familial HypercholesterolemiaAustria
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedCardiovascular Diseases | Dyslipidemia | Hypercholesterolemia | Atherosclerotic Cardiovascular DiseaseFinland, Netherlands, Spain, Belgium, Sweden, Austria, United Kingdom, Switzerland, Denmark, France, Germany, Portugal, Italy, Ireland
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaboratorsCompletedGlucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | LipodystrophyAustralia
-
Western Sydney Local Health DistrictCompletedMetabolic Syndrome | HypercholesterolemiaAustralia
-
SanofiTerminatedHypercholesterolemiaUnited States, France, Canada, Poland, Russian Federation, Germany, Netherlands, Spain, Sweden, Belgium, Czech Republic, Denmark, Hungary, Israel, Norway, Australia
-
SanofiTerminatedHypercholesterolemiaUnited States, France, Canada, Russian Federation, Ukraine, Netherlands, Bulgaria, Belgium, Czech Republic, Israel, Slovakia, Australia, South Africa
-
AmgenCompletedHypercholesterolemiaFrance, Germany, United States, Czechia, Italy, Australia, Spain, United Kingdom